$BOLT
Bolt Biotherapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$6.75
▲+7.66%+$0.480
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateBolt Biotherapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $6.57 at 09:56 AM on Oct 23, then ran to $7.78 +18% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is BOLT up today? It is at $6.75 (+7.66%), and our scanner flagged it 22 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BOLT spikes, and full due diligence on BOLT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $BOLT 22 times in the last 30 days. Create a free account to track $BOLT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on BOLT from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystMerger / acquisition agreementPrice $0.00001/shareReverse split 1-for-2Status pending stockholder approval, from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Quinn William P. Officer | Sold (automatic/other) | -9K 0.5% of company | sold 26% | 25K | $30K at $3.24 | Sep 18, 26 |
Nemec Sarah Officer | Sold (automatic/other) | -4K 0.2% of company | sold 19% | 17K | $13K at $3.24 | Sep 18, 26 |
Yonehiro Grant Officer | Sold (automatic/other) | -7K 0.4% of company | sold 28% | 17K | $22K at $3.24 | Sep 18, 26 |
Quinn William P. Officer | Sold (automatic/other) | -7K 0.3% of company | sold 16% | 35K | $22K at $3.32 | Sep 17, 26 |
Nemec Sarah Officer | Sold (automatic/other) | -3K 0.2% of company | sold 12% | 21K | $10K at $3.32 | Sep 17, 26 |
Yonehiro Grant Officer | Sold (automatic/other) | -5K 0.3% of company | sold 17% | 24K | $16K at $3.32 | Sep 17, 26 |
Quinn William P. Officer | Sold (automatic/other) | -2K 0.10% of company | sold 4.4% | 41K | $7K at $3.77 | Sep 16, 26 |
Nemec Sarah Officer | Sold (automatic/other) | -843 0.04% of company | sold 3.4% | 24K | $3K at $3.77 | Sep 16, 26 |
Yonehiro Grant Officer | Sold (automatic/other) | -1K 0.07% of company | sold 4.7% | 29K | $5K at $3.77 | Sep 16, 26 |
Quinn William P. Officer | Bought (open market) | +637 0.03% of company | added 28% | 3K | $2K at $3.88 | Jun 5, 26 |
Nemec Sarah Officer | Bought (open market) | +509 0.03% of company | added 36% | 2K | $2K at $3.88 | Jun 5, 26 |
Nemec Sarah Officer | Bought (open market) | +125 | added 9.7% | 1K | $576 at $4.61 | Dec 5, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on BOLT from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
BOLT last traded at $6.75, up 7.66% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Bolt Biotherapeutics, Inc. Common Stock (BOLT) is next expected to report earnings on Wednesday, November 11, 2026, about 17 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The BOLT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BOLT 22 times in the last 30 days.
BOLT (Bolt Biotherapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $12M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BOLT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BOLT discussion
Sign in to ask a question or join the discussion.